BE778999A - Compositions antibiotiques et leur preparation - Google Patents

Compositions antibiotiques et leur preparation

Info

Publication number
BE778999A
BE778999A BE778999A BE778999A BE778999A BE 778999 A BE778999 A BE 778999A BE 778999 A BE778999 A BE 778999A BE 778999 A BE778999 A BE 778999A BE 778999 A BE778999 A BE 778999A
Authority
BE
Belgium
Prior art keywords
preparation
antibiotic compositions
antibiotic
compositions
Prior art date
Application number
BE778999A
Other languages
English (en)
Inventor
F Dursch
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of BE778999A publication Critical patent/BE778999A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BE778999A 1971-02-05 1972-02-04 Compositions antibiotiques et leur preparation BE778999A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11310571A 1971-02-05 1971-02-05
US05/190,325 US3940483A (en) 1971-02-05 1971-10-18 Antibiotic compositions and method

Publications (1)

Publication Number Publication Date
BE778999A true BE778999A (fr) 1972-08-04

Family

ID=26810709

Family Applications (1)

Application Number Title Priority Date Filing Date
BE778999A BE778999A (fr) 1971-02-05 1972-02-04 Compositions antibiotiques et leur preparation

Country Status (9)

Country Link
US (1) US3940483A (fr)
AU (1) AU463408B2 (fr)
BE (1) BE778999A (fr)
CA (1) CA982943A (fr)
CH (1) CH541969A (fr)
DE (1) DE2205272A1 (fr)
ES (1) ES399488A1 (fr)
FR (1) FR2124499B1 (fr)
PH (1) PH11211A (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001409A (en) * 1975-05-23 1977-01-04 Bristol-Myers Company Injectable formulations of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
JPS5329936A (en) * 1976-08-31 1978-03-20 Takeda Chem Ind Ltd Antibiotic composition
US4235900A (en) * 1978-11-15 1980-11-25 E. R. Squibb & Sons, Inc. Cephradine compositions
FR2445833A1 (fr) * 1979-01-04 1980-08-01 Chimie Biolog Nouveaux sels d'antibiotiques amines a cycle beta lactame
IT1124610B (it) * 1979-10-18 1986-05-07 Zambo Spa Mono(2-ammonio-2-idrossimetil-1,3-propandiolo) (2r-cis)-(o-metilossiranil)fosfonato
ES525492A0 (es) * 1982-09-10 1985-02-01 Glaxo Group Ltd Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
KR890701104A (ko) * 1987-05-27 1989-12-19 에지.지.제이.베르미렌, 에이.디.도우마 β-락탐 항생제의 급용해성 무수 조성물
IE61679B1 (en) * 1987-08-10 1994-11-16 Fujisawa Pharmaceutical Co Water-soluble antibiotic composition and water-soluble salts of new cephem compounds
DE68922207T2 (de) * 1989-02-06 1995-11-09 Purzer Pharmaceutical Co Verfahren zur Herstellung von Alkalimetall-Salze von 3,7-substituierten 7-Aminocephalosporansauerderivaten.
NZ232763A (en) * 1989-03-06 1991-09-25 Lilly Co Eli Parenteral formulation comprising daptomycin with a buffer to maintain ph between 6.0 and 8.0
US5721229A (en) * 1995-12-26 1998-02-24 Veterinary Pharmacy Corporation Soluble forms of cephalosporins and treatment of animals
US6225304B1 (en) 1999-02-17 2001-05-01 Pharmaceutical Solutions, Inc. Soluble forms of amoxicillin and treatment of animals
US6669929B1 (en) 2002-12-30 2003-12-30 Colgate Palmolive Company Dentifrice containing functional film flakes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB895027A (en) * 1959-08-03 1962-04-26 Bristol Myers Co Therapeutic tetracycline compositions
US3136691A (en) * 1962-03-05 1964-06-09 Astra Pharma Prod Aqueous solution of local anesthetic maintained under pressure
GB1195203A (en) * 1966-06-24 1970-06-17 Glaxo Lab Ltd Cephalosporins
US3485819A (en) * 1968-07-02 1969-12-23 Squibb & Sons Inc Alpha-amino-cyclohexadienylalkylene-penicillins and cephalosporins

Also Published As

Publication number Publication date
FR2124499B1 (fr) 1975-10-10
PH11211A (en) 1977-10-28
US3940483A (en) 1976-02-24
CH541969A (fr) 1973-09-30
AU463408B2 (en) 1975-07-09
FR2124499A1 (fr) 1972-09-22
DE2205272A1 (fr) 1972-08-10
ES399488A1 (es) 1977-05-16
CA982943A (en) 1976-02-03
AU3867572A (en) 1973-08-09

Similar Documents

Publication Publication Date Title
BE810310A (fr) 4-phenylpiperidines et leur preparation
BE772940A (fr) Azetidinones-(2) et leur preparation
BE795907A (fr) 2-amino-4-arylthiazoles 5-substitues et leur preparation
BE800781A (fr) Oxathiazinones et leur preparation
BE820163A (fr) Triazolopyridazines et leur preparation
BE778999A (fr) Compositions antibiotiques et leur preparation
BE797101A (fr) Chlorothiazoles et leur preparation
BE792906A (fr) Aryl-cetones et leur preparation
BE779573A (fr) Composes de perfluoroalcane-sulfonamido-methylsiloxyle et leur preparation
BE783272A (fr) Triazolobenzodiazepines et leur preparation
BE787251A (fr) Nouvelles benzodiazepines et leur preparation
BE772990A (fr) Azetidinones-(2) et leur preparation
BE774631A (fr) Cephalosporines et leur preparation
BE765722A (fr) Compositions pigmentaires et leur preparation
BE778484A (fr) Hydroxy-alcoyl-amino alcoylene-amides et leur
BE785375A (fr) Thiolincosaminides et leur preparation
BE785024A (fr) Derives de 2-nitro-5-imidazolaldehyde et leur
BE792563A (fr) Perfluoralcane sulfonamides et leur preparation
BE761438A (fr) Alpha-halo-phenylacetamides et leur preparation
BE782846A (fr) Triazolobenzodiazepines substituees et leur preparation
BE791826A (fr) Nouveaux isocyanates et leur preparation
BE764456A (fr) Amino-3-cardenolides et leur preparation
BE763671A (fr) Azidosulfonylcarbanilates et leur preparation
BE782849A (fr) Nouvelles triazolobenzodiazepines et leur preparation
BE782848A (fr) Nouvelles triazolobenzodiazepines substituees et leur preparation

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: E.R. SQUIBB & SONS INC.

Effective date: 19920204